Our lab is dedicated to understand the interactions between microbes and the host at mucosal surfaces. We are interested in applying this knowledge to prevent and treat human and veterinary diseases. We want to understand how diet, microbiota, metabolism and immunity interact in health and disease. We are excited to announce that the Slack lab will be starting a new group at the William Dunn School of Pathology, University of Oxford from Spring 2023. If you are interested in working with us in the UK, please keep an eye here for links to open positions.
The interactions between diet, the microbiota and the host immune system
Safe and effective vaccines for application in livestock rearing.
Mechanistic understanding of food-as-therapy for microbiota/immunity-related diseases.
Our current understanding of microbiota population dynamics in the gut is based on the sequencing data or the quantification of certain strains by culture.
Claudia Eberl, Diana Ring, Philipp C. Münch, Markus Beutler, Marijana Basic, Emma C. Slack, Martin Schwarzer, Dagmar Srutkova, Anna Lange, Julia S. Frick, André Bleich and Bärbel Stecher
Frontiers in Microbiology, vol. 10, pp. 2999, Lausanne: Fontiers Research Foundation, 2020.
Claudia Eberl, Diana Ring, Philipp C. Münch, Markus Beutler, Marijana Basic, Emma C. Slack, Martin Schwarzer, Dagmar Srutkova, Anna Lange, Julia S. Frick, André Bleich and Bärbel Stecher
Frontiers in Microbiology, vol. 10, pp. 2999, Lausanne: Fontiers Research Foundation, 2020.
Oliver Pabst and Emma Slack
"Mucosal Immunology, vol. 13: no. 1, pp. 12-21, New York, NY: Nature Publishing Group, 2020."
Daniel Hoces, Markus Arnoldini, Médéric Diard, Claude Loverdo and Emma Wetter Slack
"Immunology, vol. 159: no. 1, pp. 52-62, Hoboken, NJ: Wiley, 2020."
Group Leader
Junior Group Leader
PhD Student
Intern
PhD Student
Senior Assistant
PhD Student
Research Associate
PhD Student
Intern
PhD Student
Semester Project Student
Technical Specialist
Project Manager
Senior Scientist
PhD Student
PhD Student
PhD Student
Senior assistant
Master Student
Technician
Regulatory Affairs Specialist, University Hospital Zurich
Business Developer, Angle Audio (Switzerland)
Medical Science Liaison, Novartis (Japan)
Research Associate, Biognosys (Schlieren)
Postgraduate Felllow in Clinical Development, Novartis (Switzerland)
PhD Student, Institute of Physiology, University of Zurich
Research Assistant, Department of Health Sciences and Technology (Vogel Group)
Bachelor Student, University College London
Master Student, Ludwig Maximilian University, Munich
Research Intern, Institute of Food, Nutrition and Health, ETH Zurich (Mathys Group)
Master Student, Institute of Experimental Immunology, University of Zurich
Intern, Institute of Microbiology, ETH Zurich (Hardt Group)
Master Student, ETH Zurich
Medical Student, ETH Zurich
Research Assistant, MRC Laboratory of Molecular Biology (Cambridge, England)
Master Student, ETH Zurich
Master Student, ETH Zurich
Master Student, ETH Zurich
Postdoctoral Scholar, Department of Bioengineering, Stanford University (USA)
CMC Development Associate, LimmaTech Biologics AG (Schlieren)
Master Student, ETH Zurich
Check out the latest video from the Botnar Research Centre for Child Health (BRCCH) introducing the multi-investigator research project led by Prof Emma Slack, ETH Zurich. Two very serious diseases of newborns – namely, inborn errors of metabolism and neonatal sepsis – currently have high mortality rates, long-term consequences for child development and limited treatment options. The project seeks to develop novel intervention strategies for these diseases using advancements in microbiota bioengineering.
Have a look at the video of the BRCCH introducing itself and its mission. It also includes some insights into the different research projects that have received funding in their multi-investigator project call in 2019.
Watch the SRF Puls coverage on our research on Corona virus vaccines.
Schädliche Darmbakterien mutieren und machen uns so das Leben schwer. Doch die Mutationen könnten ihnen auch zum Verhängnis werden.
Intestinal antibodies (IgA) can exert selective pressure on intestinal bacteria. Via oral vaccines, we can manipulate these selective pressures to force evolution of Salmonella that are impaired in transmitting disease. This new vaccination strategy could be used to prevent disease caused by antibiotic-resistant intestinal bacteria.
To celebrate the 50th anniversary of women's right to vote in Switzerland, the NCCR has launched a campagin introducing female researchers in Switzerland.